Response to Nab-Paclitaxel and Nedaplatin in a Heavily-Metastatic Thymic Carcinoma: A Case Report

Oncology Letters - Greece
doi 10.3892/ol.2015.2953
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

An Uncommon Response to Metronomic Therapy in a Heavily Pretreated Patient With Metastatic Carcinosarcoma: A Case Report

Journal of Medical Case Reports
Medicine
2016English

P1.14-18 the Promising Role of Sunitinib Rechallenge in Heavily Pre-Treated Thymic Carcinoma: A Case Report

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Response to Nivolumab in Metastatic Collecting Duct Carcinoma Expressing PD‑L1: A Case Report

Molecular and Clinical Oncology
Cancer ResearchOncology
2017English

Quality-Adjusted Survival With Nab -Paclitaxel vs Standard Paclitaxel in Metastatic Breast Cancer: A Q-TWiST Analysis

Clinical Breast Cancer
Cancer ResearchOncology
2018English

Metastatic Adrenal Cortical Carcinoma Responding to Octreotide: A Case Report

Oncologist
Cancer ResearchMedicineOncology
2019English

Response to Pembrolizumab in a Heavily Treated Patient With Metastatic Ovarian Carcinosarcoma

Gynecologic Oncology Research and Practice
2018English

Tumor Reduction in Primary and Metastatic Pancreatic Cancer Lesions With Nab-Paclitaxel and Gemcitabine

Pancreas
Internal MedicineEndocrinologyHepatologyMetabolismDiabetes
2017English

Role of Nab-Paclitaxel in Metastatic Breast Cancer: A Meta-Analysis of Randomized Clinical Trials

Oncotarget
Oncology
2017English

Nab-Paclitaxel for the Management of Triple-Negative Metastatic Breast Cancer

Anti-Cancer Drugs
Cancer ResearchOncologyPharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy